Abramson Cancer Center at Penn Medicine
The study is being conducted to determine if a same-day, low-dose intravenous (into a vein) injection of indocyanine green (ICG) (FDA-approved dye) being detected by using an imaging system can be a useful tool in identifying and differentiating tumor tissue from normal tissues.
Inclusion Criteria: 1. Adult patients 18 years of age and older 2. Patients presenting with a nervous system tumor presumed to be resectable and at risk for local recurrence on pre-operative assessment 3. Good operative candidates, as determined by the treating physician and multidisciplinary team 4. Subjects capable of giving informed consent Exclusion Criteria: 1. Pregnant women, as determined by urinary or serum beta hCG within 48 hours of surgery 2. Subjects with a history of iodide allergies 3. Vulnerable patient populations 4. Patients unable to participate in the consent process 5. P…
A single dose of the study drug, ICG, of less than 2 mg/kg will be administered on the day of surgery. The visualization of second window ICG for tumor will be performed approximately one to four hours after administration, depending on how long it takes for the neurosurgeon to get through the skin/skull or lamina/dura to the tumor.
Arctuva estimate
Actual pay is set by the research site.
Verify or correct the compensation shown for this listing.